Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
Disease Category: Gout (Hyperuricemia)
Location: United States, KY
Clinical Trial Details
Research Study Summary
The purpose of this study is to assess if colchicine will prevent gout attacks when subjects with gout begin taking allopurinol compared to subjects with gout taking a placebo and allopurinol.
Patient Inclusion Criteria:
Qualified participants must be at between the ages of 18 and 70 years old years old and have tophi and/or a history of gout attacks in at least 2 joints but no more than 3 joints. Other criteria also apply.
Patient Exclusion Criteria:
Qualified participants cannot have taken allopurinol, febuxostat, probenecid or sulfinpyrazone within the past 3 months and cannot have taken colchicine within the past 14 days.
To Learn more
Both Male and Female
Date Last Changed:
July 19, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these